Mechanisms of symptom generation in patients with lactose intolerance: lessons learned from validated symptom assessment during lactose breath tests

Background Lactose intolerance is a common cause of functional gastrointestinal symptoms. Traditional diagnostic strategies primarily focus on detecting malabsorption despite symptoms often occurring without it. Objectives This study examined the role of malabsorption and nonmalabsorptive mechanisms in the development of symptoms in patients with lactose intolerance. Design We analyzed 1015 patients undergoing standardized 50-g lactose hydrogen (H 2 ) breath testing with simultaneous symptom assessment using the adult Carbohydrate Perception Questionnaire. Malabsorption was defined as an H 2 increase greater than 20 ppm, and intolerance as a ≥ 20- and 35-mm increase in symptom scores. Breath test parameters and symptom patterns were compared across four groups: symptomatic malabsorbers (S+/M+), asymptomatic malabsorbers (S−/M+), symptomatic nonmalabsorbers or symptomatic absorbers (S+/M−), and asymptomatic nonmalabsorbers or asymptomatic absorbers (S−/M−). Linear and multiple regressions and receiver operating characteristic (ROC) analyses evaluated associations between H 2 kinetics and symptoms. Results Symptoms occurred frequently both with and without malabsorption: 267 (S+/M+) and 236 (S+/M−). S+/M+ patients showed higher maximal H 2 (98 vs. 59 ppm), larger area under the ROC curve (AUC) H 2 , and faster H 2 accumulation than S−/M+ (all P < 0.001). Symptom burdens were higher in S+/M+ than S+/M− (133 vs. 72 mm; P < 0.001). However, H 2 increases explained only 22% of symptom variance. In regression models, flatulence, pain, and diarrhea independently predicted malabsorption, while bloating and nausea did not. ROC performance was modest for both H 2 (AUC: 0.66) and symptoms (AUC: 0.70). Conclusion Lactose-induced symptoms arise through two partially independent mechanisms: a malabsorptive colonic fermentation pathway and a nonmalabsorptive pathway. Breath testing alone is insufficient to identify clinically relevant lactose intolerance; integrating physiological and symptom-based measures provides a more accurate mechanistic understanding.